Cargando…
A Novel Hepatic Anti-Fibrotic Strategy Utilizing the Secretome Released from Etanercept-Synthesizing Adipose-Derived Stem Cells
Tumor necrosis factor-α (TNF-α)-driven inflammatory reaction plays a crucial role in the initiation of liver fibrosis. We herein attempted to design genetically engineered adipose-derived stem cells (ASCs) producing etanercept (a potent TNF-α inhibitor), and to determine the anti-fibrotic potential...
Autores principales: | Han, Jae Hyun, Kim, Ok-Hee, Lee, Sang Chul, Kim, Kee-Hwan, Park, Jung Hyun, Lee, Jae Im, Lee, Kyung Hee, Hong, Ha-Eun, Seo, Haeyeon, Choi, Ho Joong, Ju, Ji Hyeon, Kim, Say-June |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940971/ https://www.ncbi.nlm.nih.gov/pubmed/31847135 http://dx.doi.org/10.3390/ijms20246302 |
Ejemplares similares
-
Isolation of Secretome with Enhanced Antifibrotic Properties from miR-214-Transfected Adipose-Derived Stem Cells
por: Park, Jung Hyun, et al.
Publicado: (2019) -
Ameliorating liver fibrosis in an animal model using the secretome released from miR-122-transfected adipose-derived stem cells
por: Kim, Kee-Hwan, et al.
Publicado: (2019) -
Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation
por: Lee, Jaeim, et al.
Publicado: (2019) -
Harnessing adipose-derived stem cells to release specialized secretome for the treatment of hepatitis B
por: Kim, Hee Ju, et al.
Publicado: (2021) -
A novel antifibrotic strategy utilizing conditioned media obtained from miR-150-transfected adipose-derived stem cells: validation of an animal model of liver fibrosis
por: Paik, Kwang Yeol, et al.
Publicado: (2020)